Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cachexia-Anorexia Syndrome 1

Interventions

fludarabine 5 Cyclophosphamide 5 Surgical Procedures, Operative 2 Standard of Care 2 Immune Checkpoint Inhibitors 2 Bevacizumab 2 venetoclax 1 tucatinib 1 trifluridine tipiracil drug combination 1 tremelimumab 1 trastuzumab deruxtecan 1 tislelizumab 1 tipiracil 1 spartalizumab 1 sotorasib 1 selpercatinib 1 posaconazole 1 pembrolizumab 1 peginterferon alfa-2b 1 osimertinib 1 montelukast 1 malic acid 1 icotinib 1 gallium maltolate 1 encorafenib 1 eliglustat 1 durvalumab 1 daratumumab 1 cannabigerol 1 asciminib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Not yet recruiting × selpercatinib × Clear all

NCT07146893 2026-01-15

FEATHER

University of Oklahoma

Phase EARLY_PHASE1 Not yet recruiting

Cachexia-Anorexia Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡